INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers - WBA
Portfolio Pulse from
Pomerantz LLP has filed a class action lawsuit against Walgreens Boots Alliance (WBA) alleging widespread violations of federal law in prescription drug dispensation. The lawsuit stems from a DOJ complaint that Walgreens knowingly filled millions of unlawful prescriptions between 2012-2025, violating the Controlled Substances Act and False Claims Act. Following the DOJ announcement, WBA's stock price dropped 12.06%.
March 27, 2025 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Walgreens faces potential significant financial and reputational damage from DOJ lawsuit alleging systematic opioid prescription law violations
DOJ complaint directly targets Walgreens' core business practices, suggesting potential long-term financial and regulatory consequences that could negatively impact stock performance
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100